Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Retail Industry News Amazon India opens two new fulfilment centres in Hyderabad Amazon India has expanded its fulfilment infrastructure in the South Indian state of Telangana with a couple of… bySrinathSeptember 15, 2020
